|
Nov 4
|
Opthea to Participate in November Investor Conferences
|
|
Oct 10
|
Opthea Wet AMD Program to be Presented at Innovate Retina
|
|
Oct 9
|
High Growth Tech Stocks in Australia to Watch
|
|
Oct 8
|
Opthea Appoints Chief Medical Officer and Chief Financial Officer as Company Prepares for Phase 3 Topline Data Readouts in 2025
|
|
Sep 30
|
Opthea to Participate in the UBS Virtual Ophthalmology Day 2024
|
|
Sep 5
|
Opthea Announces Executive Leadership Changes and Senior Hires
|
|
Sep 3
|
Is Opthea (OPT) The Best Australian Stock To Buy According to Hedge Funds?
|
|
Sep 3
|
Opthea to Participate in H.C. Wainwright 26th Global Investment Conference and Cantor 2024 Global Healthcare Conference
|
|
Sep 1
|
Exploring Three High Growth Tech Stocks In Australia
|
|
Aug 31
|
Opthea Full Year 2024 Earnings: Misses Expectations
|
|
Aug 30
|
Opthea Reports Full-Year Financial Results and Business Updates
|
|
Jun 19
|
Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
|
|
Dec 27
|
Opthea to Receive US$35M Commitment and Additional US$50M Funding
|
|
Dec 19
|
Opthea Receives A$8.8 million R&D Tax Incentive
|
|
Dec 1
|
Opthea to Present at the FLORetina 2023 Congress
|
|
Apr 28
|
Opthea To Participate at the H.C. Wainwright BioConnect Conference at NASDAQ
|